America pays less, on average, than any other major country for our generic drugs. But selling essential drugs at such low prices comes with hidden costs — from quality problems to frequent shortages. This is the second episode of Race to the Bottom, a three-part series by Tradeoffs on the problems plaguing the generic drugs we all rely on — and how we could fix them. Guests: Christine Baeder, MBA, President, Apotex USA Laura Bray, MBA, Founder, Angels for Change Craig Burton, Senior Vice President of Policy and Strategic Alliances, Association for Accessible Medicines Iilun Murphy, MD, Director of the Office of Generic Drugs, FDA Leslie Walker, Senior Reporter/Producer, Tradeoffs Marta Wosińska, PhD, Senior Fellow, Brookings Institution Learn more and read a full transcript on our website. Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news. Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.